To take part in this event, you must register in advance. REGISTER NOW Access the live stream from 18:00 CEST on Wednesday 30 April Overview Taking place on 30 April, 2025 (18:00-19:00 CEST), this instalment of ERS Vision Live will feature an expert panel, co-chaired by Prof. Mina Gaga and Prof. Konstantinos Kostikas, discussing type 2-low asthma.   The expert panellists will discuss key topics, including: • How do we identify type 2-low asthma? Biomarkers and their pitfalls;• Is the type 2-low asthma burden really due to asthmatic inflammation? What is the role of comorbidities?• Current and future treatments for type 2-low asthma: is there a role for biologics?   Co-Chairs   Prof. Mina Gaga • Mina is Director of the First Respiratory Medicine Department at Hygeia Hospital, Athens, Greece. • She has worked at Athens University, Royal Brompton Hospital, Imperial College, and the Greek National Healthcare Service.• Apart from clinical work, she is involved in clinical research and in medical education programs. • She has been principal investigator in multiple clinical trials, a member of the European Consortium on severe asthma and has been active internationally in guideline development for severe asthma, lung cancer screening and the requirements of delivering quality care. She has published extensively in these research areas. • She has served as a member of the HERMES Committee, Director of Learning Resources of the European Respiratory Society (ERS) School, Secretary of the European Board of Accreditation in Pneumology (EBAP), Secretary General and President of the ERS. She currently serves in the Standing Committee of the WHO-European region.         Prof. Konstantinos Kostikas • Kostas is a Professor of Respiratory Medicine at the University of Ioannina and Head of the Respiratory Medicine Department at the University Hospital of Ioannina, Greece.• He is also a Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute in Singapore.• Kostas received his training at the University of Athens Medical School, Greece, and the Royal Brompton Hospital in London, UK. His diverse career spans clinical practice, academia, and leadership roles in global medical affairs within the pharmaceutical industry.• Kostas' research interests are centred on biomarkers and mechanisms of COPD and severe asthma, along with new technologies.• He is a member of the Global Initiative for Chronic Obstructive Lung Disease COPD Assembly since 2019.     Speakers   Prof. Chris Brightling • Chris is a Fellow of the Academy of Medical Sciences, National Institute for Health Research (NIHR) Senior Investigator; Respiratory Theme Lead for NIHR Leicester Biomedical Research Centre, UK; Director for the Institute for Lung Health; Director for the Institute for Precision Health; and Honorary Consultant Respiratory Physician, Leicester, UK.• He is Coordinator of the Medical Research Council Molecular Pathology Node East Midlands Breathomics Pathology Node, Post-hospitalisation COVID-19 study and Respiratory Lead for the Innovative Medicines Initiative 3TR project.• His main research focus is on improving the clinical management and understanding the immunopathogenesis of asthma, chronic cough, COPD and long COVID. He is a member of the Global Initiative for Asthma Scientific Committee.   Prof. David Jackson • David is Professor of Respiratory Medicine at King's College London as well as Head of the Regional Severe Asthma and Eosinophilic Lung Disease Service, based at Guy's Hospital in London, UK.• He has published widely in the field of type 2 immunity, asthma and eosinophil associated diseases and co-edited the ERS Monograph on "Eosinophilic Lung Diseases" and the forthcoming ERS Monograph on "Asthma", which will be published in June 2025.• He is an Associate Editor at the journals THORAX and ALLERGY as well as Chair of the Specialist Advisory Group on Asthma for the British Thoracic Society.   Prof. Pascal Chanez